Intrabio Drug Patent Portfolio
Intrabio owns 1 orange book drug protected by 1 US patent Given below is the list of Intrabio's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11400067 | Pharmaceutical compositions and uses directed to lysosomal storage disorders | 19 Apr, 2037 | Active |
Intrabio's Family Patents
Intrabio Drug List
Given below is the complete list of Intrabio's drugs and the patents protecting them.
1. Aqneursa
Aqneursa is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11400067 | Pharmaceutical compositions and uses directed to lysosomal storage disorders |
19 Apr, 2037
(11 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Aqneursa's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List